Agios Pharmaceuticals (AGIO) Earnings Date & Reports

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

AGIO is expected to report earnings to fall 24.26% to -127 cents per share on October 29

Agios Pharmaceuticals AGIO Stock Earnings Reports

Q3'26

Est.

$-1.28

Q2'26

Missed

by $0.04

Q1'26

Beat

by $0.12

Q4'25

Beat

by $0.09

Q3'25

Beat

by $0.12

The last earnings report on July 30 showed earnings per share of -169 cents, missing the estimate of -164 cents. With 37.89K shares outstanding, the current market capitalization sits at 1.95B.

View a ticker or compare two or three

AGIO

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days